These webs of chromatin and proteins, released by immune cells to control microbial infections, could serve as a therapeutic target in coronavirus infections.

There is no evidence that any of the coronavirus vaccines in development worsen a coronavirus infection rather than confer immunity to it, but the phenomenon is something scientists are closely monitoring.

While the finding doesn’t prove people become immune to the virus after infection, it is good news for vaccine development.

The FDA cracks down on test makers as independent evaluations of their products’ performance show a need for improvement.

If governments were to use SARS-CoV-2 antibody tests to manage who can re-enter the workplace, society must accept a sacrifice of privacy.

Studies from serum samples could transform our understanding of the spread of COVID-19, but what antibodies alone say about immunity is not yet clear.

Federal agencies, academic institutions, and industrial partners are joining forces to combat COVID-19 using artificial intelligence.

Under emergency protocols, doctors can request to use survivors’ plasma to treat some critically ill COVID-19 patients.  

A small study of macaques finds they don’t develop a coronavirus infection the second time they are exposed, supporting the idea of using plasma from recovered patients as a treatment for COVID-19.